未登录

B

Bradley E. Britigan

University of Nebraska Medical Center

H指数:55

被引数:9,768

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Gallium Hematoporphyrin inhibits Mycobacteroides abscessus in vitro, including biofilm formation and stability

钴卟啉抑制脓肿分枝杆菌，包括生物膜形成和稳定性。

Bioorganic & Medicinal Chemistry Letters

IF2.2

2025-11-050

PRE

Gallium β-Cyclodextrin Nanoparticles Containing both Gallium Protoporphyrin and Gallium Nitrate Exhibit Antimicrobial Activity against Nontuberculous Mycobacteria in Vitro and in Vivo

钇β-环糊精纳米颗粒，含有钇原卟啉和钇硝酸盐，在体外和体内均表现出对非结核分枝杆菌的抗菌活性

Advanced Therapeutics

IF2.6

2025-10-050

OAAI

Efficacy and Possible Mechanism(s) of Action of Gallium Tetraphenylporphyrin Nanoparticles against HIV-TB Coinfection in an In Vitro Granuloma Structure Model

在体外肉芽肿结构模型中，镓四苯基卟啉纳米颗粒对hiv-tb共感染的功效和可能的作用机制

ACS INFECTIOUS DISEASES

IF3.8

2024-11-050

PRE

Dual Gallium Drug Treatment Against Carbapenem-Resistant Klebsiella Pneumoniae: Efficacy and Potential Mechanism(s) of Action and Resistance

ADVANCED THERAPEUTICS

IF2.6

2024-06-061

PRE

Development of Gallium(III) as an Antimicrobial Drug Targeting Pathophysiologic Iron Metabolism of Human Pathogens

ACS INFECTIOUS DISEASES

IF3.8

2023-03-305

PRE

Combining Gallium Protoporphyrin and Gallium Nitrate Enhances In Vitro and In Vivo Efficacy against Pseudomonas aeruginosa: Role of Inhibition of Bacterial Antioxidant Enzymes and Resultant Increase in Cytotoxic Reactive Oxygen Species

ACS INFECTIOUS DISEASES

IF3.8

2022-09-0114

PRE

Prolonged-acting, Multi-targeting Gallium Nanoparticles Potently Inhibit Growth of Both HIV and Mycobacteria in Co-Infected Human Macrophages (vol 5, 8824, 2015)

SCIENTIFIC REPORTS

IF3.9

2021-09-010

OAAI

Nanoparticulate β-Cyclodextrin with Gallium Tetraphenylporphyrin Demonstrates in Vitro and in Vivo Antimicrobial Efficacy against Mycobacteroides abscessus and Mycobacterium avium

ACS INFECTIOUS DISEASES

IF3.8

2021-07-2714

PREAI

Gallium Porphyrin and Gallium Nitrate Synergistically Inhibit Mycobacterial Species by Targeting Different Aspects of Iron/Heme Metabolism

ACS INFECTIOUS DISEASES

IF3.8

2020-08-2634

PREAI

Treatment of Virulent Mycobacterium tuberculosis and HIV Coinfected Macrophages with Gallium Nanoparticles Inhibits Pathogen Growth and Modulates Macrophage Cytokine Production

IF3.1

2019-08-2820

OAAI

Dual Inhibition of Klebsiella pneumoniae and Pseudomonas aeruginosa Iron Metabolism Using Gallium Porphyrin and Gallium Nitrate

ACS INFECTIOUS DISEASES

IF3.8

2019-07-0258

PREAI

Enhancing responsiveness of pancreatic Cheek for cancer cells to gemcitabine treatment under updates hypoxia by heme oxygenase-1 inhibition

TRANSLATIONAL RESEARCH

IF5.9

2019-05-0142

PREAI

Iron/Heme Metabolism-Targeted Gallium(III) Nanoparticles Are Active against Extracellular and Intracellular Pseudomonas aeruginosa and Acinetobacter baumannii

靶向铁/血红素代谢的镓 (III) 纳米颗粒对细胞外和细胞内铜绿假单胞菌和鲍曼不动杆菌具有活性

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2019-04-0148

OAAI

Gallium disrupts bacterial iron metabolism and has therapeutic effects in mice and humans with lung infections

SCIENCE TRANSLATIONAL MEDICINE

IF14.6

2018-09-26252

OAAI

Passive transfer of interferon-γ over-expressing macrophages enhances resistance of SCID mice to Mycobacterium tuberculosis infection

IF3.7

2017-07-014

PREAI

Ga(III) Nanoparticles Inhibit Growth of both Mycobacterium tuberculosis and HIV and Release of Interleukin-6 (IL-6) and IL-8 in Coinfected Macrophages

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2017-04-0139

OAAI

Gallium Compounds Exhibit Potential as New Therapeutic Agents against Mycobacterium abscessus

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2015-08-0146

OAAI

Prolonged-acting, Multi-targeting Gallium Nanoparticles Potently Inhibit Growth of Both HIV and Mycobacteria in Co-Infected Human Macrophages

SCIENTIFIC REPORTS

IF3.9

2015-03-0659

OAAI

Iron acquisition by Mycobacterium tuberculosis residing within myeloid dendritic cells

MICROBIAL PATHOGENESIS

IF3.5

2013-12-0117

PREAI

Gallium Nitrate Is Efficacious in Murine Models of Tuberculosis and Inhibits Key Bacterial Fe-Dependent Enzymes

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2013-12-0160

OAAI